Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ALAB vs MCHPP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ALAB Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

ALAB Overall Winner 6-Pillar Tally: ALAB 5 – 1 MCHPP Matrix Metrics: ALAB 8 – 2 MCHPP

As of Nov 16, 2026, Astera Labs, Inc. (ALAB) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ALAB carries a Unified Composite Score of 53.4/100 (HOLD) at $208.25 (31.0x Forward P/E, 25.5% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).

  • Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ALAB 53.4/100 HOLD), ALAB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (25.5% vs. 21.6% operating margin) and revenue trajectory (+153.7% vs. +42.2% YoY).
  • Technical & Structure Timing Caution: ALAB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.4); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ALAB vs MCHPP
ALAB NASDAQ Head-to-Head Winner
Astera Labs, Inc. Common Stock
Semiconductors & Related Devices
$208.25
-6.12% 1D
Market Cap $39.8B
TTM Revenue $1.56B
Forward P/E 31.0x
Beta / 30D Vol 4.24β · 124% Vol
Unified Composite Score
53.4 / 100 HOLD
Tech 45.0 Fund 57.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.1%), weak momentum, RSI 36
RSI-14: 36.4 · SMA20: $242.95 · SMA50: $292.18
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
TTM Revenue $5.60B
Forward P/E N/M
Beta / 30D Vol 2.16β · 65% Vol
Unified Composite Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 32
RSI-14: 32.3 · SMA20: $61.25 · SMA50: $63.22

6-Pillar Scorecard Institutional Category Breakdown (ALAB 5 – 1 MCHPP)

Columns: Metric · ALAB · MCHPP
1. Valuation Multiples ALAB
Forward P/E 31.0x N/M
Trailing P/E 90.0x N/M
PEG Ratio N/M N/M
EV / Revenue 25.6x N/M
2. Growth & Scale ALAB
Revenue Growth (YoY) +153.7% +42.2%
Earnings Growth (YoY) +98.0% N/A
TTM Revenue (USD) $1.56B $5.60B
Market Cap $39.8B N/A
3. Profitability & Quality ALAB
Gross Margin 73.9% 62.7%
Operating Margin 25.5% 21.6%
Net Profit Margin 29.6% 15.0%
Return on Equity (ROE) 28.2% 12.6%
4. Balance Sheet & Cash Flow MCHPP
Cash Generation (TTM) $345M $1.87B EBITDA
Cash Flow Margin 22.1% 33.3% EBITDA Mgn
Net Cash / Leverage $11.44 Book/Sh · 28.2% ROE $12.20 Book/Sh · 12.6% ROE
Dividend Yield None (0.00%) 6.84%
5. Options & Positioning ALAB
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 89.7% (31st %ile) N/A (N/A)
Put/Call OI Skew 1.36x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ALAB
OpEx & R&D Intensity 48.4% of Rev ($753M) 41.1% of Rev ($2.30B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Semiconductors Operator Semiconductors Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ALAB (8) vs MCHPP (2)
Institutional Metric ALAB MCHPP Criterion Row Edge
Market Capitalization
Scale
$39.8B N/A Larger Scale ALAB
Trailing P/E Ratio
Valuation
90.0x N/M Lower Multiple ALAB
Forward P/E Ratio
Valuation
31.0x N/M Lower Multiple ALAB
Revenue Growth (YoY)
Growth
+153.7% +42.2% Higher Growth ALAB
Operating Margin (TTM)
Profitability
25.5% 21.6% Higher Margin ALAB
Net Profit Margin
Profitability
29.6% 15.0% Higher Margin ALAB
Return on Equity (ROE)
Capital Efficiency
28.2% 12.6% Higher ROE ALAB
52-Week Range Position
Momentum
28% ($98–$499) 14% ($47–$88) Stronger Trend ALAB
Beta / 30D Volatility
Risk Regime
4.24β · 124% Vol 2.16β · 65% Vol Lower Realized Risk MCHPP
Unified Institutional Score
Composite Signal
53.4 / 100 (HOLD) 57.1 / 100 (HOLD) Higher Composite MCHPP
Trailing 12M Revenue (USD)
Operating Scale
$1.56B $5.60B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.9% 62.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 25.6x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$345M ($11.44 Book/Sh · 28.2% ROE) $1.87B EBITDA ($12.20 Book/Sh · 12.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MCHPP +9.73 pp
ALAB: -27.14% · MCHPP: -17.41%
3M Horizon MCHPP +9.94 pp
ALAB: -31.37% · MCHPP: -21.43%
6M Horizon ALAB +29.94 pp
ALAB: -3.4% · MCHPP: -33.34%
1Y Horizon ALAB +43.35 pp
ALAB: +44.15% · MCHPP: +0.8%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ALAB vs MCHPP. Trailing 12-month operating profitability (ALAB 25.5% vs MCHPP 21.6%) and valuation multiples (ALAB 31.0x vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ALAB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.56B
Gross Margin73.9%
Op. Margin25.5%
ROE / Fwd P/E28.2% · 31.0x
MCHPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.60B
Gross Margin62.7%
Op. Margin21.6%
ROE / Fwd P/E12.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ALAB BREAKDOWN
103d in phase · OBV NEUTRAL
Current IV 89.7%
IV Percentile 31st %ile
Put/Call OI Skew 1.36x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ALAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MCHPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MCHPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ALAB Moat Profile Scale & Operating Efficiency Moat
Semiconductors Operator
Competes within the Semiconductors value chain with $39.8B market capitalization and 25.5% operating margin.
OpEx & R&D Reinvestment 48.4% of Rev ($753M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries United Microelectronics Corporation Synopsys
MCHPP Moat Profile Scale & Operating Efficiency Moat
Semiconductors Operator
Competes within the Semiconductors value chain with N/A market capitalization and 21.6% operating margin.
OpEx & R&D Reinvestment 41.1% of Rev ($2.30B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (19 partners):
Taiwan Semiconductor Manufacturing Company United Microelectronics Corporation Amkor Technology ASE Technology Holding

Investor FAQ ALAB vs MCHPP Key Questions & Quantitative Answers

As of Nov 16, 2026, Astera Labs, Inc. (ALAB) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ALAB carries a Unified Composite Score of 53.4/100 (HOLD) at $208.25 (31.0x Forward P/E, 25.5% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ALAB 53.4/100 HOLD), ALAB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (25.5% vs. 21.6% operating margin) and revenue trajectory (+153.7% vs. +42.2% YoY). Technical & Structure Timing Caution: ALAB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.4); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ALAB leads the Growth & Scale pillar: ALAB posts +153.7% YoY revenue growth and +98.0% YoY earnings growth on $1.56B TTM revenue (73.9% gross margin, 25.5% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, ALAB generates $1.56B in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, ALAB deploys 48.4% of Rev ($753M) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.

ALAB screens cheaper on headline valuation multiples. ALAB trades at 31.0x Forward P/E, 90.0x Trailing P/E, N/M PEG, and 25.6x EV/Revenue (22.1% FCF margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ALAB (28.2% ROE) versus MCHPP (12.6% ROE) capital efficiency.

In options market volatility and institutional positioning, ALAB carries 89.7% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 1.36x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.24β · 124% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.